During the past decade, Tambov Regional Oncology Clinical Dispansary conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tambov Regional Oncology Clinical Dispansary" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Castration-Resistant Prostatic Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Tambov Regional Oncology Clinical Dispansary" in a lesser frequency.

Most popular intervention types in "Tambov Regional Oncology Clinical Dispansary" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials), "Placebo" (2 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tambov Regional Oncology Clinical Dispansary" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tambov Regional Oncology Clinical Dispansary". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tambov Regional Oncology Clinical Dispansary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tambov Regional Oncology Clinical Dispansary, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".